SERA

SEC source: 0001534969-24-000008 · wk-form4_1707342978.xml · nonDerivative · entry 1

Lindgardt Zhenya · CIK 0001891299 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 947,003

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.00 to $8.11, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

SEC source: 0001534969-24-000007 · wk-form4_1707342965.xml · nonDerivative · entry 1

Aerts Austin · CIK 0001979974 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 331,024

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.00 to $8.11, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

SEC source: 0001534969-23-000125 · wk-form4_1702002914.xml · nonDerivative · entry 1

Jackson Benjamin · CIK 0001779964 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,700

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.06 to $5.31, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F2 · balance_after: Includes 5,000 shares of Class A Common Stock purchased pursuant to the Sera Prognostics, Inc. 2021 Employee Stock Purchase Plan ("ESPP"), for the purchase period of June 1, 2023 to November 30, 2023.

SEC source: 0001534969-23-000124 · wk-form4_1702002900.xml · nonDerivative · entry 1

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,454

F1 · balance_after: Includes 5,000 shares of Class A Common Stock purchased pursuant to the Sera Prognostics, Inc. 2021 Employee Stock Purchase Plan ("ESPP"), for the purchase period of June 1, 2023 to November 30, 2023.

SEC source: 0001534969-23-000113 · wk-form4_1699478174.xml · nonDerivative · entry 1

Harrison Robert Gardner · CIK 0001421563 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,500

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over two years as follows: 1/8 of the original grant amount vests in quarterly installments for two years following the grant date, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000118 · wk-form4_1699478243.xml · nonDerivative · entry 2

Aerts Austin · CIK 0001979974 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 340,810

F2 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over two years as follows: 1/8 of the original grant amount vests in quarterly installments for two years following the grant date, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000118 · wk-form4_1699478243.xml · nonDerivative · entry 1

Aerts Austin · CIK 0001979974 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,810

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 1/16 of the original grant amount vests in quarterly installments for four years following the grant date, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000116 · wk-form4_1699478215.xml · nonDerivative · entry 1

Kearney Paul · CIK 0001888075 · Chief Data Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,050

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over two years as follows: 1/8 of the original grant amount vests in quarterly installments for two years following the grant date, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000117 · wk-form4_1699478230.xml · nonDerivative · entry 1

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,454

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over two years as follows: 1/8 of the original grant amount vests in quarterly installments for two years following the grant date, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000115 · wk-form4_1699478200.xml · nonDerivative · entry 2

Lindgardt Zhenya · CIK 0001891299 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 975,000

F2 · shares: 2. Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over two years as follows: 1/8 of the original grant amount vests in quarterly installments for two years following the grant date, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000115 · wk-form4_1699478200.xml · nonDerivative · entry 1

Lindgardt Zhenya · CIK 0001891299 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,000

F1 · shares: 1. Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 1/16 of the original grant amount vests in quarterly installments for four years following the grant date, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000114 · wk-form4_1699478188.xml · nonDerivative · entry 1

Jackson Benjamin · CIK 0001779964 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,700

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over two years as follows: 1/8 of the original grant amount vests in quarterly installments for two years following the grant date, subject to the reporting person continuing to provide services to the issuer.

F2 · balance_after: Includes 5,000 shares of Class A Common Stock purchased pursuant to the Sera Prognostics, Inc. 2021 Employee Stock Purchase Plan ("ESPP"), for the purchase period of December 1, 2022 to May 31, 2023.

SEC source: 0001534969-23-000073 · wk-form4_1688761192.xml · derivative · entry 1

Phillips Joshua · CIK 0001871555 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,265

Underlying: Class A Common Stock · 63,265 shares

Expires 2033-06-08

F1 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 8, 2023.

SEC source: 0001534969-23-000077 · wk-form4_1688761329.xml · derivative · entry 1

Lawrence Sandra AJ · CIK 0001306386 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,265

Underlying: Class A Common Stock · 63,265 shares

Expires 2033-06-08

F1 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 8, 2023.

SEC source: 0001534969-23-000079 · wk-form4_1688761417.xml · derivative · entry 1

Barlow Jane F · CIK 0001736026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,265

Underlying: Class A Common Stock · 63,265 shares

Expires 2033-06-08

F1 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 8, 2023.

SEC source: 0001534969-23-000081 · wk-form4_1688761482.xml · derivative · entry 1

Kamdar Kim P. · CIK 0001535065 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,265

Underlying: Class A Common Stock · 63,265 shares

Expires 2033-06-08

F1 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 8, 2023.

SEC source: 0001534969-23-000075 · wk-form4_1688761270.xml · derivative · entry 1

Mirza Mansoor Raza · CIK 0001588389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,265

Underlying: Class A Common Stock · 63,265 shares

Expires 2033-06-08

F1 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 8, 2023.

SEC source: 0001534969-23-000071 · wk-form4_1688761127.xml · derivative · entry 1

Trimble Ryan · CIK 0001871513 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,265

Underlying: Class A Common Stock · 63,265 shares

Expires 2033-06-08

F1 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 8, 2023.

SEC source: 0001534969-23-000059 · wk-form4_1686082069.xml · nonDerivative · entry 1

Harrison Robert Gardner · CIK 0001421563 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,500

F1 · balance_after: The Reporting Person purchased 5,000 shares of Class A Common Stock pursuant to the Sera Prognostics, Inc. 2021 Employee Stock Purchase Plan ("ESPP"), for the purchase period of December 1, 2022 to May 31, 2023.

SEC source: 0001534969-23-000034 · wf-form4_168089846797617.xml · derivative · entry 2

Kearney Paul · CIK 0001888075 · Chief Data Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 24,050 shares

Expires 2023-05-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable.

SEC source: 0001534969-23-000034 · wf-form4_168089846797617.xml · nonDerivative · entry 1

Kearney Paul · CIK 0001888075 · Chief Data Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,050

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001534969-23-000012 · wf-form4_167823653736339.xml · derivative · entry 2

CRITCHFIELD GREGORY C · CIK 0001191080 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,300

Underlying: Class A Common Stock · 98,300 shares

Expires 2033-03-07

F2 · derivative.exercise_date: These stock options vest over four years as follows: 1/48 of the original grant amount vests in monthly installments for four years following the vesting commencement date, which is March 7, 2023, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000012 · wf-form4_167823653736339.xml · nonDerivative · entry 1

CRITCHFIELD GREGORY C · CIK 0001191080 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 857,145

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 1/4 of the original grant amount vests in annual installments for four years following the vesting commencement date, which is March 7, 2023, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000014 · wf-form4_167823656489158.xml · derivative · entry 2

Altomare Nadia · CIK 0001871553 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,900

Underlying: Class A Common Stock · 28,900 shares

Expires 2033-03-06

F2 · derivative.exercise_date: These stock options vest over four years as follows: 1/48 of the original grant amount vests in monthly installments for four years following the vesting commencement date, which is March 6, 2023, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000014 · wf-form4_167823656489158.xml · nonDerivative · entry 1

Altomare Nadia · CIK 0001871553 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,300

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 1/4 of the original grant amount vests in annual installments for four years following the vesting commencement date, which is March 6, 2023, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000019 · wf-form4_167823663886064.xml · derivative · entry 2

Harrison Robert Gardner · CIK 0001421563 · Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Class A Common Stock · 45,000 shares

Expires 2033-03-06

F2 · derivative.exercise_date: These stock options vest over four years as follows: 1/48 of the original grant amount vests in monthly installments for four years following the vesting commencement date, which is March 6, 2023, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000019 · wf-form4_167823663886064.xml · nonDerivative · entry 1

Harrison Robert Gardner · CIK 0001421563 · Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,500

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 1/4 of the original grant amount vests in annual installments for four years following the vesting commencement date, which is March 6, 2023, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000017 · wf-form4_167823660648362.xml · derivative · entry 2

MOYES JAY M · CIK 0001191062 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,800

Underlying: Class A Common Stock · 51,800 shares

Expires 2033-03-06

F2 · derivative.exercise_date: These stock options vest over four years as follows: 1/48 of the original grant amount vests in monthly installments for four years following the vesting commencement date, which is March 6, 2023, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000017 · wf-form4_167823660648362.xml · nonDerivative · entry 1

MOYES JAY M · CIK 0001191062 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,630

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 1/4 of the original grant amount vests in annual installments for four years following the vesting commencement date, which is March 6, 2023, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000018 · wf-form4_167823662277643.xml · derivative · entry 2

Jackson Benjamin · CIK 0001779964 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,100

Underlying: Class A Common Stock · 39,100 shares

Expires 2033-03-06

F2 · derivative.exercise_date: These stock options vest over four years as follows: 1/48 of the original grant amount vests in monthly installments for four years following the vesting commencement date, which is March 6, 2023, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000018 · wf-form4_167823662277643.xml · nonDerivative · entry 1

Jackson Benjamin · CIK 0001779964 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,700

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 1/4 of the original grant amount vests in annual installments for four years following the vesting commencement date, which is March 6, 2023, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000016 · wf-form4_167823659033280.xml · derivative · entry 2

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,900

Underlying: Class A Common Stock · 34,900 shares

Expires 2033-03-06

F2 · derivative.exercise_date: These stock options vest over four years as follows: 1/48 of the original grant amount vests in monthly installments for four years following the vesting commencement date, which is March 6, 2023, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000016 · wf-form4_167823659033280.xml · nonDerivative · entry 1

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,454

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 1/4 of the original grant amount vests in annual installments for four years following the vesting commencement date, which is March 6, 2023, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000015 · wf-form4_167823657771124.xml · derivative · entry 2

Kearney Paul · CIK 0001888075 · Chief Data Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,300

Underlying: Class A Common Stock · 25,300 shares

Expires 2033-03-06

F2 · derivative.exercise_date: These stock options vest over four years as follows: 1/48 of the original grant amount vests in monthly installments for four years following the vesting commencement date, which is March 6, 2023, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000015 · wf-form4_167823657771124.xml · nonDerivative · entry 1

Kearney Paul · CIK 0001888075 · Chief Data Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,000

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 1/4 of the original grant amount vests in annual installments for four years following the vesting commencement date, which is March 6, 2023, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000013 · wf-form4_167823655156888.xml · derivative · entry 2

Foley Michael R · CIK 0001892321 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,700

Underlying: Class A Common Stock · 42,700 shares

Expires 2033-03-06

F2 · derivative.exercise_date: These stock options vest over four years as follows: 1/48 of the original grant amount vests in monthly installments for four years following the vesting commencement date, which is March 6, 2023, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-23-000013 · wf-form4_167823655156888.xml · nonDerivative · entry 1

Foley Michael R · CIK 0001892321 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,000

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 1/4 of the original grant amount vests in annual installments for four years following the vesting commencement date, which is March 6, 2023, subject to the reporting person continuing to provide services to the issuer.

SEC source: 0001534969-22-000125 · wf-form4_166275463160358.xml · derivative · entry 2

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 844 shares

Expires 2022-09-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable.

SEC source: 0001534969-22-000125 · wf-form4_166275463160358.xml · nonDerivative · entry 1

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,354

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001534969-22-000118 · wf-form4_165896241981247.xml · derivative · entry 4

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 844

Underlying: Class A Common Stock · 1,000 shares

Expires 2022-09-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable.

SEC source: 0001534969-22-000118 · wf-form4_165896241981247.xml · nonDerivative · entry 3

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,510

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2021.

SEC source: 0001534969-22-000118 · wf-form4_165896241981247.xml · nonDerivative · entry 2

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,510

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001534969-22-000118 · wf-form4_165896241981247.xml · nonDerivative · entry 1

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,510

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2021.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.01 to $2.27, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001534969-22-000116 · wf-form4_165827385603500.xml · nonDerivative · entry 1

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,235

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2021.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.81 to $1.93, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001567619-22-014188 · doc1.xml · nonDerivative · entry 3

Blue Ox Healthcare Partners, LLC · CIK 0001873840 · 10% owner

Blue Ox Healthcare Partners SP, LLC · CIK 0001785138 · 10% owner

BXHCP SP II, LLC · CIK 0001804589 · 10% owner

BXHCP SP III, LLC · CIK 0001862000 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By BXHCP SP III, LLC

Disclosed balance after: 46,744

F1 · kind: Shares have been distributed pro rata for no consideration to certain members of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC in accordance with the required distribution of marketable securities stipulation in the respective Limited Liability Company Agreements.

F2 · ownership.nature: Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares.

SEC source: 0001567619-22-014188 · doc1.xml · nonDerivative · entry 2

Blue Ox Healthcare Partners, LLC · CIK 0001873840 · 10% owner

Blue Ox Healthcare Partners SP, LLC · CIK 0001785138 · 10% owner

BXHCP SP II, LLC · CIK 0001804589 · 10% owner

BXHCP SP III, LLC · CIK 0001862000 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By BXHCP SP II, LLC

Disclosed balance after: 77,420

F1 · kind: Shares have been distributed pro rata for no consideration to certain members of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC in accordance with the required distribution of marketable securities stipulation in the respective Limited Liability Company Agreements.

F2 · ownership.nature: Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares.

SEC source: 0001567619-22-014188 · doc1.xml · nonDerivative · entry 1

Blue Ox Healthcare Partners, LLC · CIK 0001873840 · 10% owner

Blue Ox Healthcare Partners SP, LLC · CIK 0001785138 · 10% owner

BXHCP SP II, LLC · CIK 0001804589 · 10% owner

BXHCP SP III, LLC · CIK 0001862000 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Blue Ox Healthcare Partners SP, LLC

Disclosed balance after: 132,501

F1 · kind: Shares have been distributed pro rata for no consideration to certain members of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC in accordance with the required distribution of marketable securities stipulation in the respective Limited Liability Company Agreements.

F2 · ownership.nature: Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares.

SEC source: 0001534969-22-000114 · wf-form4_165774278495450.xml · nonDerivative · entry 1

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,960

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2021.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.78 to $1.92, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001534969-22-000111 · wf-form4_165706061574192.xml · nonDerivative · entry 1

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,685

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2021.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.59 to $1.74, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001534969-22-000109 · wf-form4_165654363063215.xml · derivative · entry 4

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,844

Underlying: Class A Common Stock · 1,000 shares

Expires 2022-09-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable.